Skin Cancer and Reconstructive Surgery (SCARS) Center Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Skin Cancer and Reconstructive Surgery (SCARS) Center's estimated annual revenue is currently $4.5M per year.(i)
  • Skin Cancer and Reconstructive Surgery (SCARS) Center's estimated revenue per employee is $189,000

Employee Data

  • Skin Cancer and Reconstructive Surgery (SCARS) Center has 24 Employees.(i)
  • Skin Cancer and Reconstructive Surgery (SCARS) Center grew their employee count by -8% last year.

Skin Cancer and Reconstructive Surgery (SCARS) Center's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M5-81%N/AN/A
#2
$17M70-4%N/AN/A
#3
$4.9M264%N/AN/A
#4
$10.2M4718%N/AN/A
#5
$0.7M5-92%N/AN/A
#6
$66.2M2239%N/AN/A
#7
$12.6M5227%N/AN/A
#8
$53.2M179-2%N/AN/A
#9
$5.1M27-10%N/AN/A
#10
$22.1M824%N/AN/A
Add Company

What Is Skin Cancer and Reconstructive Surgery (SCARS) Center?

Skin Cancer and Reconstructive Surgery Center is Orange County’s premiere skin cancer center, offering patients, physicians, and the community a credible, reliable, and convenient resource for understanding, preventing, and managing skin cancer. More Information: Skin Cancer and Reconstructive Surgery Center is dedicated to diagnosis, treatment, and prevention of skin cancers. SCARS Center is a leading skin cancer education source for healthcare professionals and patients, offering regular CME accredited skin cancer conferences for physicians and providing patients with multiple options for skin cancer prevention, treatment, and recovery. Our facilities include a patient clinic, Mohs laboratory, surgery center, radiation facility, and conference center. Read more at ocskincancer.com.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$4.5M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M24-4%N/A
#2
$2.5M2414%N/A
#3
$3.7M25-4%N/A
#4
$3.5M25-14%N/A
#5
$2.5M25-11%N/A